retatrutide safety profile clinical trials Test results on a popular unapproved peptide have revealed a concentration double that listed on the label, prompting warnings from health professionals about "enormous" overdose risks. By national health equity reporters Caitlyn Efficacy and safety of retatrutide,

In order to make GLP-1 better used in the clinic, drug developers modified its structure and developed a series of GLP-1R agonists (13)

For the other 88.8%, side effects were manageable enough to continue through 48 weeks

However, several products do allow limited room temperature storage before first use according to their FDA labels: Wegovy (semaglutide): Up to 28 days at or below 86F (30C) before use Trulicity (dulaglutide): Up to 14 days at or below 86F (30C) before use Mounjaro and Zepbound (tirzepatide): Up to 21 days at or below 86F (30C) before use Bydureon BCise (exenatide extended-release): Up to 4 weeks at or below 77F (25C) before use When storing unopened GLP-1 medications, patients should keep them in their original carton to protect them from light exposure, which can also degrade the active ingredient

Susan Spratt, an endocrinologist and the senior medical director for the Population Health Management Office at Duke Health in North Carolina, questioned whether the increased risk was due to the rapid weight loss or some other mechanism of the drug